Clinical Trials Browser

INDUSTRY × Pancreatic Neoplasms × Filgrastim × Clear all

NCT01858883 2019-07-18

Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01822756 2018-02-12

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Phase 1 Terminated

42 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms